Bhagiradha Chemicals reported its highest-ever Q1 FY27 performance.

Revenue jumped 58% to 195.0 Cr, EBITDA surged 240% to 30.5 Cr, and PAT rose 235% to 13.3 Cr.

Growth fueled by new molecule launches, Bheema Fine Chemicals ramp-up, and strategic shift to high-margin products.

Warrants subscribed to fund expansion.